Increased cell density decreases cysteine proteinase inhibitor activity and increases invasive ability of two prostate tumor cell lines

Cancer Letters

Volumn 185, Issue 2, 2002, Pages 163-172

  Colella, Rita ^a   Goodwyn, Erik ^a   Gopal, Purva ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cathepsins L and B; Cell density; Cysteine proteinase inhibitors; Invasion; Prostate tumor cell lines PC3 and DU145

Indexed keywords

CATHEPSIN B; CATHEPSIN L; CELL EXTRACT; CYSTATIN; CYSTEINE PROTEINASE INHIBITOR; MATRIGEL; CATHEPSIN; COLLAGEN; CYSTEINE PROTEINASE; LAMININ; PROTEOGLYCAN; TUMOR PROTEIN;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CELL DENSITY; CELL INTERACTION; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR CELL LINE; ADENOCARCINOMA; CELL COUNT; CELL CULTURE; COMPARATIVE STUDY; CULTURE MEDIUM; CYTOLOGY; DRUG COMBINATION; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM CELL; LYSOSOME; MALE; PATHOLOGY; PHYSIOLOGY; PROSTATE; PROSTATE TUMOR;

ADENOCARCINOMA; CATHEPSIN B; CATHEPSINS; CELL COUNT; COLLAGEN; COMPARATIVE STUDY; CULTURE MEDIA, CONDITIONED; CYSTEINE PROTEINASE INHIBITORS; DRUG COMBINATIONS; EPITHELIAL CELLS; HUMAN; LAMININ; LYSOSOMES; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROSTATE; PROSTATIC NEOPLASMS; PROTEOGLYCANS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; HUMANS;

EID: 0037191505     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00275-6     Document Type: Article

References (64)

1. Proteases of cell adhesion proteins in cancer
2. Metalloproteinase in tumor progression: The contribution of MMP-9
3. Tumor-associated urokinase-type plasminogen activator: Biological and clinical significance
4. Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: Increased PA activity correlates with biologically aggressive behavior
5. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B
6. Expression of cathepsins B and S in the progression of prostate carcinoma
7. Cathepsins B, H, L and cysteine proteinase inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue
8. Plasma membrane associated cysteine proteinases in human and animal tumors
9. Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts
10. Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues
11. Collagenolytic cathepsins of rabbit spleen: A kinetic analysis of collagen degradation and inhibition by chicken cystatin
12. Elastinolytic activity of human cathepsin L
13. Degradation of laminin by tumor cathepsin B
14. "In vitro" study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like, and L
15. Evolution of proteins of the cystatin superfamily
16. Anticarcinogenic activities of naturally occurring cysteine proteinase inhibitors
17. Mammalian cysteine proteinase inhibitors: Biochemical properties and possible role in tumor progression
18. Cystatins in health and disease
19. Demonstration of proteinase inhibitors cystatin A, B and C in breast cancer and in cell lines MCF-7 and ZR-75-1
20. Inhibitory properties of low molecular weight cysteine proteinase inhibitor from human sarcoma
21. Stefin B, the major low molecular weight inhibitor in ovarian carcinoma
22. Increased expression of cathepsins B and L, and decreased activity of their inhibitors, in metastatic, ras-transformed NIH 3T3 cells
23. Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact
24. Cell-cell contact down-regulates expression of membrane type metalloproteinase-1 (MT1-MMP) in a mouse mammary gland epithelial cell line
25. Urokinase receptor expression is upregulated by cell culture sparsity in breast cancer cell line BT-20
26. Density-dependent regulation of cell-surface association of matrix metalloproteinase-2 (MMP-2) in breast-carcinoma cells
27. Expression of mucin-associated tumor antigens is altered by cell density
28. Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: Involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat
29. Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells
30. Cathepsin B, cathepsin H and cathepsin L
31. Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts
32. Activity of lysosomal cysteine proteinases during differentiation of rat skeletal muscle
33. Protein measurement with the folin phenol reagent
34. L-trans-epoxysuccinyl-leucylamido-(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L
35. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B
36. Inhibition of carcinoma cell invasion and liver metastasis formation by the cysteine proteinase inhibitor - E-64
37. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade
38. Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion
39. Characterization of low molecular mass cysteine proteinase inhibitors from human amniotic fluid
40. Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines
41. Regulation of cell migration by the calcium-dependent protease calpain
42. An intracellular form of cathepsin B contributes to invasiveness in cancer
43. Imaging proteolysis by living human glioma cells
44. The role of cathepsin L in malignant transformation
45. Microenvironment-induced cancer metastasis
46. Putting tumours in context
47. Drp, a novel protein expressed at high cell density but not during growth arrest
48. Expression of acid cysteine proteinase inhibitor (ACPI) in the normal prostate, benign prostatic hyperplasia and adenocarcinoma
49. Cell density mediated pericellular hypoxia leads to induction of HIF-1α via nitric oxide and Ras/MAP kinase mediated signaling pathways
50. 2+ channels
51. Modulation of epithelial morphogenesis and cell fate by cell-to-cell signals and regulated cell adhesion (review)
52. Aberrant E-cadherin and α-catenin expression in prostate cancer: Correlation with patient survival
53. Complex cadherin expression in human prostate cancer cells
54. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects
55. Relationship of hypoxia to metastatic ability in rodent tumours
56. Hypoxia modulated gene expression: Angiogenesis, metastasis and therapeutic exploitation
57. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression
58. Exposure to hypoxia, glucose starvation and acidosis: Effect on invasive capacity of murine tumor cells and correlation with cathepsin (L+B) secretion
59. An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells
60. Studies of type IV collagenase regulation by hypoxia
61. Molecular cloning of mouse epidermal cystatin A and detection of regulated expression in differentiation and tumorigenesis
62. Growth stimulation of 3T3 fibroblasts by cystatin
63. Cysteine proteinase inhibitors and ras gene products share the same biological activities including transforming activity toward NIH3T3 mouse fibroblasts and the differentiation-inducing activity toward PC12 rat pheochromocytoma cells
64. Increase of cyclin B by overexpression of cystatin alpha